NCCN Updates Guidelines for Central Nervous System (CNS) Cancers

NCCN recently updated the NCCN Guidelines for Central Nervous System (CNS) Cancers. Important new updates include the recommendation to use bevacizumab as a single agent for recurrent glioblastoma multiforme in CNS cancers, the integration of a patient's Karnofsky Performance Status (KPS) score into treatment decisions, and an adjusted age range for adjuvant therapy options in patients with low grade gliomas. May 18, 2009 FORT WASHINGTON, PA - The National Comprehensive Cancer Network (NCC...
Source: National Comprehensive Cancer Network - Category: Cancer & Oncology Source Type: news